First Time Loading...

Reata Pharmaceuticals Inc
NASDAQ:RETA

Watchlist Manager
Reata Pharmaceuticals Inc Logo
Reata Pharmaceuticals Inc
NASDAQ:RETA
Watchlist
Price: 172.36 USD
Updated: May 15, 2024

Reata Pharmaceuticals Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Reata Pharmaceuticals Inc
Pre-Tax Income Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Reata Pharmaceuticals Inc
NASDAQ:RETA
Pre-Tax Income
-$87.7m
CAGR 3-Years
38%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Pre-Tax Income
$20.1B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
2%
Bristol-Myers Squibb Co
NYSE:BMY
Pre-Tax Income
-$5.8B
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Pre-Tax Income
-$1.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck & Co Inc
NYSE:MRK
Pre-Tax Income
$3.9B
CAGR 3-Years
-13%
CAGR 5-Years
-18%
CAGR 10-Years
-4%
Eli Lilly and Co
NYSE:LLY
Pre-Tax Income
$7.6B
CAGR 3-Years
2%
CAGR 5-Years
20%
CAGR 10-Years
5%

See Also

What is Reata Pharmaceuticals Inc's Pre-Tax Income?
Pre-Tax Income
-87.7m USD

Based on the financial report for Jun 30, 2023, Reata Pharmaceuticals Inc's Pre-Tax Income amounts to -87.7m USD.

What is Reata Pharmaceuticals Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-11%

Over the last year, the Pre-Tax Income growth was 71%. The average annual Pre-Tax Income growth rates for Reata Pharmaceuticals Inc have been 38% over the past three years , -11% over the past five years .